NCT00047060View on ClinicalTrials.gov

Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 30, 2002

Primary Completion Date

January 24, 2019

Study Completion Date

January 24, 2019

Conditions
Mycosis FungoidesSezary Syndrome
Interventions
OTHER

A matched peripheral donor stem cells

A matched peripheral donor stem cells

DRUG

cyclosporine

cyclosporine

DRUG

fludarabine

fludarabine

DRUG

Campath

Campath

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00047060 - Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome | Biotech Hunter | Biotech Hunter